Anavex Life Sciences Ends Equity Offering Program
Company Announcements

Anavex Life Sciences Ends Equity Offering Program

Anavex Life Sciences (AVXL) has issued an announcement.

Anavex Life Sciences Corp. has ended its agreement with Cantor Fitzgerald & Co. and SVB Securities LLC for an at-the-market equity offering program. The company had the option to sell shares of its common stock through this program at its discretion. The termination of this agreement, which took place on July 24, 2024, did not result in any penalties for Anavex.

For an in-depth examination of AVXL stock, go to TipRanks’ Stock Analysis page.

Related Articles
TheFlyAnavex presents new data from blarcamesine study at CTAD conference
TheFlyAnavex announces preliminary biomarker results from Phase 2 study of ANAVEX 3-71
TheFlyLargest borrow rate increases among liquid names
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App